Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-25 @ 8:11 PM
Study NCT ID:
NCT01969435
Status:
COMPLETED
Last Update Posted:
2018-02-13
First Post:
2013-10-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-19
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-16
First Submit QC Date:
None
Study First Post Date:
2013-10-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-21
Results First Submit QC Date:
None
Results First Post Date:
2016-11-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-16
Last Update Post Date:
2018-02-13
Last Update Post Date Type:
ACTUAL